EUVIMEDEUVIMED entdecken
Crossref

Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs

Yuyang Chen, Xiaofang Huang, Zizheng Guo, Jingyu Zhang, Lixin Zhang, Renke Dai iD

Journal of Chromatographic Science · 2025

DOI: 10.1093/chromsci/bmad092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2025. Verfasst von Yuyang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou, Guangdong 511436, China. Hauptthemen laut MEDLINE: Ivermectin, Antiparasitic Agents. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Science and Technology Bureau of Qingyuan City, Guangdong Province, China, Qingyuan High-tech Zone, East China University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivermectin has been widely used for antiparasitic drug, and has recently shown a broad-spectrum antiviral activity, including anti-Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacokinetic property of ivermectin has not been fully investigated yet. During the plasma preparation, ~32–46% of ivermectin was found in the precipitation. An Liquid Chromatograph-Mass Spectrometer (LC–MS/MS) method for ivermectin in the whole blood samples from beagle dogs was developed and validated. The specificity, accuracy, precision (intra-day and inter-day), matrix effect, recovery and stability of analyte reported here are satisfied with the criteria of Food and Drug Administration (FDA)-Bioanalysis guideline. The oral administrations pharmacokinetics of ivermectin in beagle dogs under fasting and after high-fat meal were studied, and the following parameters were obtained: fasting Cmax, 104 ± 35 μg·L−1; area under the concentration–time curve (AUC0–∞), 2,555 ± 941 h·μg·L−1; and high-fat meal Cmax, 147 ± 35 μg·L−1; AUC0–∞, 4,198 ± 1,279 h·μg·L−1. When the P-gp inhibitor curcumin was also coadministrated orally, Cmax and AUC0–∞ were found to be 177 ± 57 and 4,213 ± 948 h·μg·L−1, respectively. With the comparison to fasting treatment, coadministration of P-gp inhibitor curcumin resulted in increase of the exposure of ivermectin by 1.6-fold, while the exposure after the high-fat diet versus fasting was increased approximately in 1.4-fold, indicating that alternative absorption might play an important role for increasing the exposure of ivermectin for future clinic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvermectinAntiparasitic AgentsAnimalsDogsTandem Mass SpectrometryMaleChromatography, LiquidReproducibility of ResultsAdministration, OralLinear ModelsArea Under CurveLimit of DetectionFemaleSensitivity and SpecificityDrug Stability

Substanzen

IvermectinAntiparasitic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Guangzhou Medical University, Xinzao, Panyu District, Guangzhou, Guangdong 511436, China.
  • Guangdong Ruigu Biotech Corporation, 18 Chuangxing Road, High-tech Zone, Qingyuan, Guangdong 511517, China.
  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Road, Xuhui District, Shanghai 200237, China.

ORCID-Profile: Renke Dai

Förderung

  • Science and Technology Bureau of Qingyuan City, Guangdong Province, China
  • Qingyuan High-tech Zone
  • East China University of Science and Technology

Zitieren

APA

Chen, Y., Huang, X., Guo, Z., Zhang, J., Zhang, L., & Dai, R. (2025). Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmad092

Vancouver

Chen Y, Huang X, Guo Z, Zhang J, Zhang L, Dai R. Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs. Journal of Chromatographic Science. 2025. doi:10.1093/chromsci/bmad092

BibTeX
@article{Chen2025,
  author = {Chen, Yuyang and Huang, Xiaofang and Guo, Zizheng and Zhang, Jingyu and Zhang, Lixin and Dai, Renke},
  title = {Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs},
  journal = {Journal of Chromatographic Science},
  year = {2025},
  doi = {10.1093/chromsci/bmad092}
}
Kostenlos starten →